世界の医療産業における3Dプリンティング市場動向・研究開発・売上予測...市場調査レポートについてご紹介

【英文タイトル】3D Printing for Healthcare, Trends, R&D and Revenue Forecasts 2016-2026 : Explore Dental Products, Medical Implants, Pharmaceuticals, Bio-printing and Other Uses for Additive Manufacturing

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

1. Report Overview
1.1 Overview of 3D Printing for Healthcare: R&D, Industry and Market 2016-2026
1.2 Why You Should Read This Report
1.3 How This Report Delivers
1.4 Main Questions Answered by This Analytical Report
1.5 Who is This Report For?
1.6 Methods of Research and Analysis
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain

2. Introduction to the 3D Printing for the Healthcare Industry
2.1 3D Printing
2.1.1 Stereolithography – The First 3D Printing Method
2.1.2 Selective Laser Sintering (SLS), Direct Metal Laser Sintering (DMLS) and Selective Laser Melting (SLM)
2.1.3 Electron Beam Melting (EBM)
2.2 Bio-printing Organic Living Cells
2.2.1 Approaches to Bio-printing
2.2.2 Applications for Bio-printing
2.3 3D Printing Pharmaceuticals
2.4 Classifying Medical Devices
2.4.1 The US Medical Devices Classification System
2.4.2 The EU Medical Device Classification System

3. The 3D Printing Healthcare Global Market 2016-2026
3.1 The Current State of the 3D Printing for Healthcare Market
3.2 3D Printed Products in the Healthcare Industry: Submarket Breakdown
3.2.1 Dental Product Submarket is still the Current Majority Market Share Holder
3.3 Global Forecast for the 3D Printed Market 2016-2026
3.4 Drivers and Restraints for the Global 3D Printed Healthcare Market
3.4.1 Drivers of the Global 3D Printed Healthcare Market
3.4.2 Restraints for the 3D Printed Healthcare Market
3.5 The 3D Printing Market for Healthcare: Technology vs. Products Revenue Forecast
3.5.1 Technology: Revenue Forecast 2016-2026
3.5.2 Drivers and Restraints for the 3D Printed Healthcare Technology Submarket
3.5.3 Products Revenue Forecast 2016-2026
3.5.4 Drivers and Restraints for the 3D Printed Healthcare Products Submarket
3.6 The 3D Printing Market for Healthcare: Product Submarket Revenue Forecasts 2016-2026
3.6.1 Dental Products: Revenue Forecast 2016-2026
3.6.2 Medical Implants: Revenue Forecast 2016-2026
3.6.2.1 Medical Implants: Patient-Specific Orthopaedic and Cranio-maxillofacial Implants Are Produced Using 3D Printing Technology
3.6.2.2 Drivers and Restraints for the 3D Printed Medical Implants, 2016
3.6.2.3 FDA Approvals for 3D Printed Medical Implants
3.6.3 Bio-printed Tissue: Revenue Forecast 2016-2026
3.6.4 Bio-printed Tissue: Commercial Uses
3.6.4.1 Bio-printed Liver Tissue: Preclinical Drug Testing
3.6.4.2 Bio-printed Skin: Opportunities in Cosmetics and Burn Victims
3.6.4.3 Bio-printed Cartilage: Facial Disfigurements and Knee Replacements
3.6.5 Other Applications: Revenue Forecast 2016-2026
3.6.5.1 3D Printed Surgical Tools: Accurate yet Expensive
3.6.5.2 3D Printed Medical Modelling
3.6.5.3 3D Printed Pharmaceuticals: 2015 Sees the First FDA Approval
3.6.5.4 3D Printing to Help Combat Cancer

4. Leading National Markets for 3D Printing in Healthcare 2016-2026
4.1 Leading National Markets for 3D Printing in Healthcare, 2016
4.2 Leading National Markets for 3D Printing in Healthcare, 2020
4.3 Leading National Markets for 3D Printing in Healthcare, 2026
4.4 The US will be the Dominant Market in 3D Printed Healthcare for the Duration of the Forecast
4.4.1 America Makes: A ‘National Accelerator’ for US 3D Printed Products
4.4.2 FDA Regulatory Requirements: Abridged Pathways Encourage Innovation
4.5 The EU5 Will Account for almost third of the Market in 2016; How Will This Change over the Coming 10 years?
4.5.1 Germany Will Remain the Largest Market of the EU5 Throughout the Forecast Period
4.5.2 France Demonstrates Strong Growth but a Deceasing Market Share
4.5.3 The UK: A Strong Network for 3D Printed Medical Implants Will Stimulate Sales of those Products
4.5.4 Italian Orthopaedic Manufacturers are Prominent Consumers of AM Technology
4.5.5 Spain has the Smallest 3D Printing for Healthcare Market in the EU5
4.6 Japan Will be Overtaken as the Second Largest Market by China in 2017
4.7 The BRIC Nations Show Strong Growth from 2020-2026
4.7.1 China: Domestic Innovation is Keeping Pace with the West
4.7.1.1 Chinese Market Restraints to 3D Printing for Healthcare
4.8 Russian Recession Creates Challenges from 2015-2019
4.9 Brazil’s Rapidly Growing Dental Market Presents Opportunities for 3D Printing
4.10 The Indian Market is in its Infancy
4.11 The Rest of The World Market is Fast Growing

5. Market Leading Organisations
5.1 Market Leaders in Technology: Hardware and Software
5.1.1 Stratasys: Activities and Outlooks
5.1.1.1 Growth Strategies for Stratasys
5.1.2 3D Systems: Achievements and Activities
5.1.3 EOS: A Market Leader in the Technology Submarket
5.1.4 Autodesk Within: Autodesk Acquires Within Technologies
5.1.5 Renishaw: UK-based 3D Printer Manufacturer
5.2 Market Leaders in the Medical Implant/Dental Product Submarkets
5.2.1 Tissue Regeneration Systems: Commercialising 3D Printed Bioresorbable Skeletal Reconstruction Implants
5.2.2 Oxford Performance Materials: Innovators with FDA Approvals to Match
5.2.3 C&A Tool: Manufacturing Parts for the Surgical, Orthopaedic, Implant and Tooling Fields
5.2.4 Tronrud Engineering: A Provider
5.2.5 Aortica: Abdominal Aortic Aneurysm Specialists
5.2.6 Proto Labs Acquires Alphaform AG
5.2.7 3T RPD Ltd: A Large Contributor to the U.K. National Market
5.2.8 Arcam AB: Acquisitions Give Coverage of the Entire Production Line
5.2.9 Xilloc Medical: Patient-Specific Implants from Design to Production.
5.2.10 Fripp Design and Research: Commercial Products in the Pipeline
5.2.11 Materialise NV: A Global Software and Printing Services Provider
5.2.12 4WEB Medical: Strong Growth with More in the Pipeline
5.2.13 Replica 3dm: Offering Medical Models for the NHS
5.2.14 Zdravprint: 3D Printed Casts
5.3 Leading Organisations in the 3D Bio-printing Submarket
5.3.1 Organovo: the First Bio-printed Tissue on the Market
5.3.1.1 Organovo exVive 3D Bio-printed Liver Tissue
5.3.1.2 Organovo: 3D Printed Kidney Tissue in the Pipeline
5.3.2 RegenHU: Creating 3D Bio-printers and Bioinks
5.3.3 Bio 3D Technologies: The World’s First Modular Bio-printer
5.3.4 Osteopore International: Two FDA Approved Products
5.3.5 EnvisionTEC: 3D Printing and Bio-printing Solutions
5.3.6 Dentca
5.3.7 Rainbow Biosciences: Bio-printing based on Magnetic Nanoparticles
5.3.8 Wake Forest Institute for Regenerative Medicine: 3D Bio-printing Research
5.3.8.1 Bio-printed Tissue for Drug Development
5.4 When will Bio-printing be Commercially Available?
5.5 3D Printed Pharmaceuticals: Was 2015 a Watershed Year for the Pharmaceutical Industry?
5.5.1 Aprecia Pharmaceuticals Receives FDA Approval for Spritam, the First of a Kind
5.5.2 The Cronin Group, University of Glasgow: Research into 3D Printing Pharmaceuticals
5.5.3 FabRx: Changing the Shape of Drugs

6. 3D Printing for the Healthcare Industry: The R&D Pipeline
6.1 The Pipeline for 3D Printed Medical Implants
6.1.1 3D Printed Tracheal Splints
6.1.2 Improving Biocompatibility of 3D Printed Medical Implants
6.1.2.1 Vitamin B2 Can Improve Biocompatibility of 3D Printed Medical Implants
6.1.2.2 Silicone is a Biocompatible Material Which Can be Used to Encase Implants
6.1.3 3D Printing for Spinal Implants
6.1.3.1 3D Printed Titanium Spinal Implants
6.1.3.2 3D Printed Intervertebral Discs Could Look Forward to a Share of a $90bn Market
6.1.3.3 3D Printing to Help Treat Babies With Spina Bifida
6.1.4 Printing a Bionic Eye
6.2 The Pipeline for 3D Printed Bioengineering
6.2.1 3D Printing Human Skin
6.2.2 3D Printing Cartilage: Research Making Commercial Availability Tangible
6.2.3 3D Printing Vascular Tissue is a Complex Challenge Restraining the Bio-printing of Entire Organs
6.2.3.1 Revotek: Creating a Blood Vessel Printer
6.2.3.2 Bio-ink Research at Harvard University
6.2.3.3 3D Printed Thryroid Gland – the First 3D Printed Organ?
6.2.3.4 Sugar and Silicone Casted Blood Vessels
6.2.3.5 The Artivasc 3D Project at the Fraunhofer Institute
6.2.4 3D Printing to Fabricate Artificial Heart Valves
6.2.5 3D Printing of the Nipple Areola Complex Graft for Reconstructive Surgery
6.2.6 3D Printing Stem Cells
6.3 The Pipeline for Other 3D Printed Healthcare Applications
6.3.1 Eyedrivomatic: A 3D Printed Wheelchair
6.3.2 3D Printed Pharmaceuticals: Changing Dose, Shape and API
6.3.2.1 3D Printed Polypill for Cardiovascular Disease
6.3.2.2 3D Printing New Active Pharmaceutical Ingredients
6.3.2.3 Aprecia Have Three Products in their Pipeline
6.3.2.4 Bringing Pharmaceuticals to Lesser Economically Developed Countries
6.3.3 3D Printed Microbots for Healthcare

7. Qualitative Analysis of the 3D Printing Industry for Healthcare, 2016-2026
7.1 Strengths of the 3D Printing for Healthcare Industry
7.1.1 Growth Rates Are High – 3D Printing Holds Great Potential
7.1.2 Demand for Customised Products is Increasing
7.1.3 3D Printed Products Can Improve Health Outcomes and Reduce Costs Incurred on Health Systems
7.1.4 More Efficient Use of Economic Resources in Manufacturing
7.1.5 3D Printing Produces Complex Shapes and Parts
7.1.6 3D Printing Technology is Advancing Rapidly
7.2 Weaknesses of the 3D Printing for Healthcare Industry
7.2.1 3D Printing is Expensive Technology
7.2.2 Traditional Economies of Scale Cannot Yet be Achieved with AM
7.2.3 AM is a New Technology which Requires Fewer Workers and New Expertise
7.2.4 Access to Technology and Expertise is Currently Limited
7.2.5 New Legislation will be Enforced Which Could Slow Advances
7.3 Opportunities for the 3D Printing for Healthcare Market, 2016-2026
7.3.1 Governments are Funding 3D Printing R&D Projects
7.3.2 Increasing Demand for Personalised Medicine Represents a Lucrative Opportunity
7.3.3 New Applications for 3D Printing Technology are Being Developed
7.3.4 Post-Production Finishing Will Require New Expertise
7.4 Threats to the 3D Printing for Healthcare Industry, 2016-2026
7.4.1 Regulatory Guidelines Must be Clarified
7.4.2 A Media Coverage May Lead to An Investment Bubble
7.4.3 High Volume Manufacturing is More Economical Using Traditional Methods
7.4.4 There May be Unknown Side Effects Harmful to Health
7.5 A STEP Analysis of the 3D Printing for Healthcare Market
7.6 Social Influences on the 3D Printing for Healthcare Market
7.7 Technological Influences on Market Trends
7.8 Economic Influences on the Market
7.9 Political Influences on the Market

8. Research Interviews
8.1 Interview with Dr Stephen Hilton, UCL School of Pharmacy, FabRx, 3D Synthesis
8.1.1 On 3D Printing Research at UCL, FabRx and 3D Synthesis
8.1.2 On the Use of Hardware and Software
8.1.3 On Commercial Ambitions for FAbRx
8.1.4 On the Benefits and Barriers to 3D Printing in Healthcare
8.2 Interview with Evan Youngstrom, Venture Counsel, Wilson Sonsini Goodrich & Rosati Professional Corporation
8.2.1 On Intellectual Property Challenges
8.2.2 On the Different Challenges Between Implants and Pharmaceuticals
8.2.3 On the First FDA Approved 3D Printed Drug
8.3 Interview with Peter Leys, Executive Chairman, Materialise N.V
8.3.1 On the Beginning of Materialise N.V.
8.3.2 On the Medical Products and Services Offered by Materialise N.V.
8.3.3 On Materialise’s Most Lucrative Products and Markets in 2015 and Beyond
8.3.4 On Regulatory Challenges Facing 3D Printing in the Healthcare Industry
8.3.5 On the Prospects of Materialise N.V. Over the Forecast Period
8.4 Interview with Michael Renard, Executive Vice President, Commercial Operations, Organovo
8.4.1 On the Application for 3D Bio-printing
8.4.2 On the Commercial Prospects of the Technology
8.4.3 On the Potential Factors That Could Inhibit Development
8.4.4 On their Newly Released exVive 3D Liver Human Tissue
8.4.5 On the Future of Organovo and the 3D Bio-printing Industry
8.5 Interview with Jim Fitzsimmons, President and CEO, Tissue Regeneration Systems
8.5.1 On the Background of TRS
8.5.2 On TRS’ Portfolio
8.5.3 On Their Commercialization Strategy
8.5.4 Future
8.6 Interview with Matthew Sherry, Managing Director, Replica 3dm
8.6.1 On the History Behind Replica 3dm
8.6.2 On Their Services and R&D Pipeline
8.6.3 On Replica 3DM’s Growth Plans
8.6.4 On the 3D Printing for Healthcare Industry
8.7 Interview with Lee Cronin, Regius Chair of Chemistry, University of Glasgow
8.7.1 On the Cronin Group’s 3D Printed Technology
8.7.2 On Commercialisation Opportunities for Their Technology

9. Conclusions from Our Study
9.1 The Overall 3D Printing for Healthcare Market can be Broken Down into Technology and Products
9.2 Revenue for 3D Printed Healthcare Product Submarkets 2016-2026
9.3 Leading National Markets for 3D Printing in the Healthcare Industry 2016-2026
9.4 Market Trends for 3D Printing in Healthcare 2016-2026
9.4.1 Centralised Organisations will Foster Growth
9.4.2 Opportunities in Technology Development and Raw Material Production
9.4.3 Increased Demand for Personalised Products is leading to Greater Penetration of Technology
9.4.4 3D Printing is Most Established in the Product Submarket of Dentistry
9.4.5 2015 Was a Landmark Year for the 3D Printed Pharmaceuticals
9.4.6 Bio-printing Will Start to Bring in Commercial Revenue Within the Forecast Period
9.4.7 Concluding Remarks


【レポート販売概要】

■ タイトル:世界の医療産業における3Dプリンティング市場動向・研究開発・売上予測
■ 英文:3D Printing for Healthcare, Trends, R&D and Revenue Forecasts 2016-2026 : Explore Dental Products, Medical Implants, Pharmaceuticals, Bio-printing and Other Uses for Additive Manufacturing
■ 発行日:2016年2月
■ 調査会社:visiongain
■ 商品コード:VGAIN6022515
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。